Delivery Order SPE2DB20D2104-SPE2DB25FMYYM
- Not listed
- The Defense Logistics Agency awarded a $15,269.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro 2.5 mg/0.5 mL pens on August 11, 2025, with an ultimate completion date of August 12, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $4,515.92 to AmerisourceBergen Drug Corp for Mounjaro 2.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-competitive delivery order represents a firm fixed-price pharmaceutical supply transaction to be performed at the vendor's Conshohocken, Pennsylvania location. Mounjaro is a diabetes medication, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical products...
- The Defense Logistics Agency awarded a delivery order valued at $40,974.26 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication that represents part of the broader pharmaceutical...
- The Defense Logistics Agency awarded a $1,904.63 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL). This competitively awarded, non-set-aside contract is scheduled for completion by September 5, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $8,703.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $39,675.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 mL pens on September 4, 2025, with an ultimate completion date of September 5, 2025. This is a non-set-aside competitive award issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pens with a contract ceiling value of $22,038.06. This firm fixed-price delivery order, which will be completed by August 20, 2025, represents a competitively awarded non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a $6,530.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on July 30, 2025, with an ultimate completion date of July 31, 2025. This non-competitive delivery order represents a single pharmaceutical product delivery executed under the company's existing contract vehicle with DLA. Mounjaro is a tirzepatide-based diabetes medication, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a $2,496.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 ml pens on July 22, 2025, with an ultimate completion date of July 23, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation, and...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $14,323.06 on August 13, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYYMDelivery Order
The Defense Logistics Agency awarded a $5,420.32 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This firm fixed-price contract, which is a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, represents a competitively awarded procurement with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. Mounjaro is a diabetes medication used in the treatment of type 2 diabetes, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical products supplied to federal military and veteran healthcare systems. This delivery order is part of AmerisourceBergen's comprehensive $999.999 billion IDC with DLA Troop Support Medical (SPE2DX contract vehicle through December 2026), which enables the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical vendor in the federal medical procurement ecosystem, AmerisourceBergen regularly fulfills such delivery orders across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 8/27/25 |